Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
520 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Treatment of pediatric alopecia areata: A systematic review.
Barton VR, Toussi A, Awasthi S, et al. · J Am Acad Dermatol · 2022Systematic Review, Research Support, N.I.H., Extramural
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1).
King B, Senna MM, Mesinkovska NA, et al. · J Am Acad Dermatol · 2024Clinical Trial, Phase III, Randomized Controlled Trial
- Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis.
Perez SM, Vattigunta M, Kelly C, et al. · Dermatol Surg · 2025Systematic Review, Meta-Analysis
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
King B, Zhang X, Harcha WG, et al. · Lancet · 2023Randomized Controlled Trial, Multicenter Study
- Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis.
Liu M, Gao Y, Yuan Y, et al. · JAMA Netw Open · 2023Meta-Analysis, Systematic Review
- Treatments for alopecia areata: a network meta-analysis.
Mateos-Haro M, Novoa-Candia M, Sánchez Vanegas G, et al. · Cochrane Database Syst Rev · 2023Systematic Review, Research Support, Non-U.S. Gov't
- Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH, Gwillim E, Patel KR, et al. · J Am Acad Dermatol · 2020Meta-Analysis, Systematic Review
- Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis.
Cruciani M, Masiello F, Pati I, et al. · Blood Transfus · 2023Meta-Analysis, Systematic Review
- Onion juice (Allium cepa L.), a new topical treatment for alopecia areata.
Sharquie KE, Al-Obaidi HK · J Dermatol · 2002Clinical Trial, Controlled Clinical Trial
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review.
Olbrich H, Sadik CD, Ludwig RJ, et al. · Biomolecules · 2023Systematic Review, Research Support, Non-U.S. Gov't
- Minoxidil.
Fiedler-Weiss VC · Dermatol Clin · 1987Clinical Trial, Review
- Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, et al. · N Engl J Med · 2022Clinical Trial, Phase III, Randomized Controlled Trial
- Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis.
Lee JH, Ju HJ, Seo JM, et al. · J Invest Dermatol · 2023Meta-Analysis, Systematic Review
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial.
King B, Ko J, Kwon O, et al. · JAMA Dermatol · 2024Randomized Controlled Trial, Multicenter Study
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O, Senna MM, Sinclair R, et al. · Am J Clin Dermatol · 2023Randomized Controlled Trial, Clinical Trial, Phase III
- Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study.
Tziotzios C, Sinclair R, Lesiak A, et al. · J Eur Acad Dermatol Venereol · 2025Clinical Trial, Phase III, Multicenter Study
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial.
Hordinsky M, Hebert AA, Gooderham M, et al. · Pediatr Dermatol · 2023Clinical Trial, Phase II, Clinical Trial, Phase III
- Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.
Toussi A, Barton VR, Le ST, et al. · J Am Acad Dermatol · 2021Systematic Review
- Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Guttman-Yassky E, Renert-Yuval Y, Bares J, et al. · Allergy · 2022Clinical Trial, Phase II, Randomized Controlled Trial
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis.
Wang H, Chen M, Wang T, et al. · Front Immunol · 2025Meta-Analysis, Systematic Review
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata.
Aceituno D, Fawsitt CG, Power GM, et al. · J Eur Acad Dermatol Venereol · 2025Comparative Study, Systematic Review
- Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis.
Ly S, Manjaly P, Kamal K, et al. · Am J Clin Dermatol · 2023Meta-Analysis, Systematic Review
- Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
Milani M, Colombo F · Skin Res Technol · 2023Randomized Controlled Trial
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis.
Wei D, Chen Y, Shen Y, et al. · Front Immunol · 2023Systematic Review, Research Support, Non-U.S. Gov't
- Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials.
Jafarzadeh A, Pour Mohammad A, Keramati H, et al. · Stem Cell Res Ther · 2024Systematic Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.